Literature DB >> 11009575

Review of cryptogenic fibrosing alveolitis, including current treatment guidelines.

S C Bourke1, H Clague.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11009575      PMCID: PMC1741775          DOI: 10.1136/pmj.76.900.618

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  44 in total

1.  British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society.

Authors:  I D Johnston; R J Prescott; J C Chalmers; R M Rudd
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

Review 2.  Viruses and idiopathic pulmonary fibrosis.

Authors:  J J Egan; A A Woodcock; J P Stewart
Journal:  Eur Respir J       Date:  1997-07       Impact factor: 16.671

3.  Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction.

Authors:  K Kuwano; Y Nomoto; R Kunitake; N Hagimoto; T Matsuba; Y Nakanishi; N Hara
Journal:  Eur Respir J       Date:  1997-07       Impact factor: 16.671

Review 4.  Lung transplantation.

Authors:  E P Trulock
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

5.  Idiopathic pulmonary fibrosis: predicting response to therapy and survival.

Authors:  S E Gay; E A Kazerooni; G B Toews; J P Lynch; B H Gross; P N Cascade; D L Spizarny; A Flint; M A Schork; R I Whyte; J Popovich; R Hyzy; F J Martinez
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

6.  The prognosis of cryptogenic fibrosing alveolitis.

Authors:  B H Stack; Y F Choo-Kang; B E Heard
Journal:  Thorax       Date:  1972-09       Impact factor: 9.139

7.  Natural history and treated course of usual and desquamative interstitial pneumonia.

Authors:  C B Carrington; E A Gaensler; R E Coutu; M X FitzGerald; R G Gupta
Journal:  N Engl J Med       Date:  1978-04-13       Impact factor: 91.245

8.  Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.

Authors:  R Hubbard; A Venn; C Smith; M Cooper; I Johnston; J Britton
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

9.  Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis.

Authors:  J A Bjoraker; J H Ryu; M K Edwin; J L Myers; H D Tazelaar; D R Schroeder; K P Offord
Journal:  Am J Respir Crit Care Med       Date:  1998-01       Impact factor: 21.405

Review 10.  Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects.

Authors:  R G Crystal; J D Fulmer; W C Roberts; M L Moss; B R Line; H Y Reynolds
Journal:  Ann Intern Med       Date:  1976-12       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.